Sources of variation of Helicobacter pylori treatment success in adults worldwide: A meta-analysis

International Journal of Epidemiology

Volumn 31, Issue 1, 2002, Pages 128-139

  Fischbach, Lori A ^a,b   Goodman, Karen J ^a   Feldman, Mark ^b   Aragaki, Corinne ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Drug resistance; Helicobacter pylori; Meta analysis; Prevalence world health; Review; Treatments

Indexed keywords

AMOXICILLIN; BISMUTH; BISMUTH CITRATE; CIMETIDINE; CLARITHROMYCIN; FURAZOLIDONE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METRONIDAZOLE; NITROIMIDAZOLE; OMEPRAZOLE; OXYTETRACYCLINE; PROTON PUMP INHIBITOR; RANITIDINE; RANITIDINE BISMUTH CITRATE; TETRACYCLINE; TINIDAZOLE;

DISEASE CONTROL; DRUG RESISTANCE; HEALTH CARE; META-ANALYSIS;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ASIA; CALCULATION; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; META ANALYSIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SHORT COURSE THERAPY; STATISTICAL MODEL; TREATMENT OUTCOME;

HELIOBACTERIUM;

EID: 0036205372     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/31.1.128     Document Type: Article

References (62)

1. Ueber das spirillum des saugetiermagens und sein verhalten zu den belegzellen
2. Unidentified curved bacilli on gastric epithelium in active chronic gastritis
3. Unidentified curved bacilli on gastric epithelium in active chronic gastritis
4. The prevalence of Helicobacter pylori infection in different countries
5. The epidemiology of Helicobacter pylori infection
6. Ecological study of association between Helicobacter pylori infection and gastric cancer in Taiwan
7. Helicobacter pylori infections in the developing world. Summary of a workshop organized at the International Center for Diarrhoeal Disease Research, Bangladesh
8. Helicobacter pylori infection in north-eastern peninsular Malaysia: Evidence for an unusually low prevalence
9. Antibody response to Campylobacter pylori in an ethnic group lacking peptic ulceration
10. Schistosomes, Liver Flukes and Helicobacter pylori. IARC Monographs on the Evaluation of Cancer Risks to Humans
11. Helicobacter pylori in peptic ulcer disease
12. Peptic disease: Can we afford current management?
13. Therapy and prevention of gastric ulcer
14. Medical treatment of peptic ulcer disease: Practice guidelines
15. Treatment of Helicobacter pylori infection: A review of the world literature
16. Current European concepts in the management of Helicobacter pylori infection
17. Review of Helicobacter pylori eradication regimens
18. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection
19. Bias in the one-step method for pooling study results
20. Treatment of Helicobacter pylori infection: A review
21. Meta-analysis
22. Patient factors affecting Helicobacter pylori eradication with triple therapy
23. Factors influencing the eradication of Helicobacter pylori with triple therapy
24. Eradication of Helicobacter pylori: An objective assessment of current therapies
25. Evaluation of treatment regimens to cure Helicobacter pylori infection - A meta-analysis
26. Which factors influence the success of the classical triple therapy in the eradication of Helicobacter pylori?
27. Helicobacter pylori infections in the developing world
28. A critical look at some popular meta-analytic methods
29. Quality scores are useless and potentially misleading. Reply to 'Re: A critical look at some popular analytic methods'
30. The hazards of scoring the quality of clinical trials for meta-analysis
31. Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature
32. Pitfalls in Helicobacter pylori diagnosis
33. What is the true impact of metronidazole resistance on the efficacy of bismuth-triple therapy?
34. Randomized trial for eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers
35. Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong
36. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: Randomized controlled trial
37. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China
38. An increase in Helicobacter pylori strains resistant to metronidazole: A five year study
39. Dual therapy versus triple therapy for Helicobacter pylori-associated duodenal ulcers
40. A new quadruple therapy for Helicobacter pylori: Influence of resistant strains on treatment outcome
41. Helicobacter pylori antibiotic resistance: Trends over time
42. Campylobacter pylori - Therapy review
43. One-week low-dose triple therapy: New standards for Helicobacter pylori treatment
44. Review articles: The treatment of Helicobacter pylori infection
45. Eradicating Helicobacter pylori
46. Treatment strategies for Helicobacter pylori infection
47. Eradication of Helicobacter pylori: Therapies and clinical implications
48. Therapeutic attempts at eradication of Campylobacter pylori
49. Review article: Treatments that impact favorably upon the eradication of Helicobacter pylori and ulcer recurrence
50. Indications for treatment of Helicobacter pylori infection: A systematic overview
51. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease
52. Meta-analysis of the effect of antibiotic therapy in eradicating Helicobacter pylori
53. Treatment of Helicobacter pylori infection
54. Eradication of Helicobacter pylori infection
55. Which combination therapy can eradicate 90% Helicobacter pylori (H Pylori) infection? A meta-analysis of amoxicillin, metronidazole, tetracycline and clarithromycin containing regimens
56. Review article: Clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease
57. Antimicrobial treatment of H. pylori infection - A pooled efficacy analysis of eradication therapies
58. A comparison of statistical methods for combining event rates from clinical trials
59. Meta-analysis: Unresolved issues and future developments